IO Biotech (IOBT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist

0.771
+0.011+1.43%

Close Dec 20 16:00 ET

0.750
-0.021-2.70%

Post 20:01 ET

50.79MMarket Cap-0.60P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

IO Biotech Secures €57.5 Million EIB Loan Facility
TipRanksDec 20 08:27 ET
Express News | IO Biotech Inc: Debt Facility Expected to Extend Company's Cash Runway Into Q2 of 2026
ReutersDec 20 08:06 ET
Express News | IO Biotech Inc: Funds Expected to Be Used to Advance IO Biotech's Immune-Modulating Therapeutic Cancer Vaccines
ReutersDec 20 08:06 ET
Express News | IO Biotech Secures up to €57.5 Million in Debt Financing From the European Investment Bank
ReutersDec 20 08:05 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaNov 22 16:06 ET
TD Cowen Maintains IO Biotech(IOBT.US) With Buy Rating
Moomoo NewsNov 12 20:31 ET · Ratings

Comments

Trytosaveabit

Dec 20 07:09

News

$IO Biotech (IOBT.US)$ Reuters· 3 mins ago
IO Biotech Secures up to €57.5 Million in Debt Financing From the European Investment Bank

Jaguar8

Nov 7 09:02

NEWS

$IO Biotech (IOBT.US)$
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...